Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Gavosto

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Leukemia Research|January 1, 1985
In-vitro effect of retinoic acid on normal and chronic myeloid leukemia granulopoiesisM Aglietta, W Piacibello, A Stacchini, et al.
Leukemia|November 1, 1992
Has IL2 a role in the management of minimal residual disease for acute leukemia?R Foa, G Meloni, A Guarini, et al.
Tumori|August 31, 1989
N-ras mutations in myeloid leukemiasG Saglio, A Serra, A Novarino, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale|February 28, 1970
[Study of the survival of the non-proliferative fraction of blast cells of acute leukemia]V Gabutti, P Masera, R P Tarocco, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|October 1, 1991
Oncology in the nineties: from genes to therapyF Gavosto, M Aglietta, F Caligaris Cappio, et al.
Haematologica|November 1, 1990
IL-2 in the treatment of chronic myeloid leukemia after lymphoid blast crisis: a pilot studyG Meloni, R Foà, S Tosti, et al.
Pharmacological Research|September 1, 1992
Interleukin 2 in the management of hematologic malignanciesR Foà, G Meloni, A Guarini, et al.
British Journal of Haematology|September 1, 1981
Idiopathic myelofibrosis: a possible role for immune-complexes in the pathogenesis of bone marrow fibrosisF C Cappio, R Vigliani, A Novarino, et al.
Cancer|November 15, 1993
Short-term administration of granulocyte-macrophage colony stimulating factor decreases hematopoietic toxicity of cytostatic drugsM Aglietta, C Monzeglio, P Pasquino, et al.
Leukemia & Lymphoma|July 28, 2016
Induction and Persistence of Complete Remission in a Resistant Acute Myeloid Leukemia Patient after Treatment with Recombinant Interleukin-2R Foà, M T Fierro, S Tosti, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Leukemia Research|January 1, 1985
In-vitro effect of retinoic acid on normal and chronic myeloid leukemia granulopoiesisM Aglietta, W Piacibello, A Stacchini, et al.
Leukemia|November 1, 1992
Has IL2 a role in the management of minimal residual disease for acute leukemia?R Foa, G Meloni, A Guarini, et al.
Tumori|August 31, 1989
N-ras mutations in myeloid leukemiasG Saglio, A Serra, A Novarino, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale|February 28, 1970
[Study of the survival of the non-proliferative fraction of blast cells of acute leukemia]V Gabutti, P Masera, R P Tarocco, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|October 1, 1991
Oncology in the nineties: from genes to therapyF Gavosto, M Aglietta, F Caligaris Cappio, et al.
Haematologica|November 1, 1990
IL-2 in the treatment of chronic myeloid leukemia after lymphoid blast crisis: a pilot studyG Meloni, R Foà, S Tosti, et al.
Pharmacological Research|September 1, 1992
Interleukin 2 in the management of hematologic malignanciesR Foà, G Meloni, A Guarini, et al.
British Journal of Haematology|September 1, 1981
Idiopathic myelofibrosis: a possible role for immune-complexes in the pathogenesis of bone marrow fibrosisF C Cappio, R Vigliani, A Novarino, et al.
Cancer|November 15, 1993
Short-term administration of granulocyte-macrophage colony stimulating factor decreases hematopoietic toxicity of cytostatic drugsM Aglietta, C Monzeglio, P Pasquino, et al.
Leukemia & Lymphoma|July 28, 2016
Induction and Persistence of Complete Remission in a Resistant Acute Myeloid Leukemia Patient after Treatment with Recombinant Interleukin-2R Foà, M T Fierro, S Tosti, et al.
Pageof 8